31-Dec-14 There's been a lot going on in emerging markets in 2014. Here's a look back at 12 notable Medtech and Healthcare growth markets stories that you may have missed, month-by-month, including "Indonesia’s new national health insurance scheme", "Korea to nurture medical device industry", "Turkey’s pharma market is ripe for profit", "China healthcare draws investors" and more.

14-Jan-15 Overall, the Chinese government created lots of space for the private sector in 2014, meaning demand remained strong and companies benefited. This trend is likely to continue in 2015, especially if initiatives such as online drug sales, foreign participation in health services, and more funding for doctors’ pay, CFDA and telemedicine, are continued. [image: Forbes]

09-Jan-15 While drug makers say local regulators are ill-equipped and inadequately staffed to monitor them, the watchdogs in turn hold state governments responsible for failing to strengthen the supervisory mechanism. "The governments were in a mad rush to attract investments by creating tax havens but did not pay enough attention to… quality standards," a state drug controller said, admitting inadequacies in the system. [image: The Economic Times / BCCL]

08-Jan-15 The Food & Drug Administration in Taiwan has reiterated its determination to facilitate easy access to drugs to further promote responsible self-medication, which it says can save people time waiting in hospitals and clinics, as well as considerable National Health Insurance spending. [image: GBI Research]

08-Jan-15 Korea’s domestic pharmaceutical R&D industry progressed strongly in 2014, securing approval of its 21st domestically developed drug, Liavax, and the entry of new medicines such as Kanarb and Supect onto the global market. In 2015 new Korean drugs for chemo-induced neutropenia, obesity and arthritis are expected to hit the market, as well as several new vaccines. [image: Business Korea]